The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term survival in patients (pts) with locally advanced or disseminated malignant melanoma (MM) or renal cell carcinoma (RCC), treated with tag-7 gene-modified (GMV) tumor cells: A phase II trial.
 
Alexey Viktorovich Novik
Speakers' Bureau - BioCad; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
 
Anna Borisovna Danilova
No Relationships to Disclose
 
Irina Alexandrovna Baldueva
Speakers' Bureau - AstraZeneca
 
Maksim Ivanovich Sluzhev
No Relationships to Disclose
 
Tatyana Leonidovna Nehaeva
No Relationships to Disclose
 
Sergei Larin
No Relationships to Disclose
 
Svetlana Protsenko
Speakers' Bureau - BioCad; Bristol-Myers Squibb; Merck Sharp & Dome; Novartis; Pierre Fabre; Roche
Research Funding - Amgen; AstraZeneca; BioCad; Bristol-Myers Squibb; Merck Sharp & Dome; Novartis; Roche
 
Anna Semenova
No Relationships to Disclose
 
Aleksei Olegovich Danilov
No Relationships to Disclose
 
Vladimir Moiseyenko
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dome; Novartis; Roche
Research Funding - AstraZeneca; BioCad; Bristol-Myers Squibb; Cancer Advances; Lilly; Merck Sharp & Dome
 
Georgii Pavlovich Georgiev
No Relationships to Disclose